TBPH (THERAVANCE BIOPHARMA INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 3 institutional investors hold TBPH (THERAVANCE BIOPHARMA INC) with a combined value of $80.39M across 4,296,725 shares. The largest holder is BlackRock, Inc. with a position worth $75.79M (0.00% of their portfolio). 2 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$80.39M
Total Shares Held
4,296,725
Institutional Holders
3
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $75.79M | 0.00% | -0.5% |
| 2 | CITADEL ADVISORS LLC | $4.41M | 0.00% | +363.4% |
| 3 | Point72 Asset Management, L.P. | $196.46K | 0.00% | +0.0% |